I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 19 studies | 27% ± 10% | |
| astrocyte | 11 studies | 28% ± 12% | |
| microglial cell | 10 studies | 24% ± 9% | |
| oligodendrocyte | 10 studies | 27% ± 9% | |
| glutamatergic neuron | 9 studies | 43% ± 25% | |
| oligodendrocyte precursor cell | 9 studies | 26% ± 11% | |
| adipocyte | 9 studies | 28% ± 7% | |
| GABAergic neuron | 8 studies | 40% ± 22% | |
| macrophage | 8 studies | 26% ± 10% | |
| fibroblast | 7 studies | 25% ± 7% | |
| interneuron | 6 studies | 38% ± 24% | |
| myeloid cell | 6 studies | 21% ± 6% | |
| epithelial cell | 6 studies | 32% ± 13% | |
| dendritic cell | 6 studies | 22% ± 6% | |
| type I pneumocyte | 6 studies | 22% ± 6% | |
| smooth muscle cell | 6 studies | 22% ± 5% | |
| neuron | 5 studies | 31% ± 11% | |
| ciliated cell | 5 studies | 21% ± 4% | |
| endothelial cell of lymphatic vessel | 5 studies | 31% ± 9% | |
| club cell | 5 studies | 21% ± 6% | |
| pericyte | 5 studies | 24% ± 8% | |
| type II pneumocyte | 5 studies | 21% ± 4% | |
| basal cell | 5 studies | 27% ± 12% | |
| natural killer cell | 4 studies | 19% ± 2% | |
| retinal cone cell | 4 studies | 25% ± 5% | |
| mast cell | 4 studies | 20% ± 4% | |
| lymphocyte | 4 studies | 24% ± 8% | |
| monocyte | 4 studies | 27% ± 3% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 16% ± 0% | |
| GABAergic interneuron | 3 studies | 25% ± 4% | |
| glial cell | 3 studies | 18% ± 1% | |
| B cell | 3 studies | 19% ± 2% | |
| amacrine cell | 3 studies | 24% ± 5% | |
| retina horizontal cell | 3 studies | 18% ± 4% | |
| hepatocyte | 3 studies | 36% ± 25% | |
| abnormal cell | 3 studies | 27% ± 15% | |
| T cell | 3 studies | 19% ± 1% | |
| alveolar macrophage | 3 studies | 27% ± 7% | |
| goblet cell | 3 studies | 40% ± 28% | |
| transit amplifying cell | 3 studies | 30% ± 19% |
